Rapt Therapeutics Inc (NASDAQ:RAPT)
| 17.59 Delayed Data As of Dec 02 |  +0.07 / +0.40%Today’s Change | 9.86 Today|||52-Week Range 40.74 | -52.11% Year-to-Date |
Latest RAPT News | Press Releases
| Why RAPT Therapeutics (RAPT) Stock Might be a Great Pick Nov 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 17.52 |
| Today’s open | 17.30 |
| Day’s range | 17.30 - 17.95 |
| Volume | 11,185 |
| Average volume (3 months) | 327,229 |
| Market cap | $607.0M |
Data as of 4:00pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | -15.29% |
| Earnings growth (this year) | -1.78% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -24.38% |
| P/E ratio | NM |
| Price/Sales | 263.85 |
| Price/Book | 2.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EBSEmergent BioSolution... | +0.19 | +1.61% |
| SGMOSangamo Therapeutics... | +0.08 | +2.25% |
| BNGOBionano Genomics Inc | +0.10 | +5.05% |
| SRNESorrento Therapeutic... | +0.03 | +2.44% |
Data as of 4:00pm ET, 12/02/2022
Financials
| Next reporting date | March 9, 2023 |
| EPS forecast (this quarter) | -$0.67 |
| Annual revenue (last year) | $3.8M |
| Annual profit (last year) | -$69.2M |
| Net profit margin | -1,814.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
